Literature DB >> 30692864

Performance and Capacity Measurement of the Lower Extremities in Multiple Sclerosis -How to Approach?

Sıla Usar İncirli1, Özlem Taşkapilioğlu2.   

Abstract

Walking limitations play a key role in the development of disability in multiple sclerosis (MS) patients. Vast majority of patients, even in the very early stages of the disease, experience walking disturbances. Measuring capacity and performance in lower extremities enables us to 1) monitor disease pregression; 2) evaluate treatment responses; 3) determine the necessity of new treatment strategies on time. The purpose of this review is to highlight the importance of regular walking assessments in MS patients, give idea about which measurement tools to choose, and provide insight for future investigations in the light of new technological developments.

Entities:  

Keywords:  Lower extremities; capacity; measurement; multiple sclerosis; perfomenace

Year:  2018        PMID: 30692864      PMCID: PMC6278627          DOI: 10.29399/npa.23352

Source DB:  PubMed          Journal:  Noro Psikiyatr Ars        ISSN: 1300-0667            Impact factor:   1.339


  50 in total

Review 1.  The Multiple Sclerosis Functional Composite Measure (MSFC): an integrated approach to MS clinical outcome assessment. National MS Society Clinical Outcomes Assessment Task Force.

Authors:  J S Fischer; R A Rudick; G R Cutter; S C Reingold
Journal:  Mult Scler       Date:  1999-08       Impact factor: 6.312

Review 2.  Rating scales for neurologists.

Authors:  J Hobart
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-12       Impact factor: 10.154

3.  Day-to-day variability of maximum walking distance in MS patients can mislead to relevant changes in the Expanded Disability Status Scale (EDSS): average walking speed is a more constant parameter.

Authors:  H Albrecht; C Wötzel; L P Erasmus; M Kleinpeter; N König; W Pöllmann
Journal:  Mult Scler       Date:  2001-04       Impact factor: 6.312

4.  Muscle strength and fatigue during isokinetic exercise in individuals with multiple sclerosis.

Authors:  C P Lambert; R L Archer; W J Evans
Journal:  Med Sci Sports Exerc       Date:  2001-10       Impact factor: 5.411

Review 5.  The pathology of multiple sclerosis and its evolution.

Authors:  H Lassmann
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-10-29       Impact factor: 6.237

6.  Gait abnormalities in minimally impaired multiple sclerosis patients.

Authors:  M G Benedetti; R Piperno; L Simoncini; P Bonato; A Tonini; S Giannini
Journal:  Mult Scler       Date:  1999-10       Impact factor: 6.312

7.  The patient's perception of a (reliable) change in the Multiple Sclerosis Functional Composite.

Authors:  E L J Hoogervorst; N F Kalkers; G R Cutter; B M J Uitdehaag; C H Polman
Journal:  Mult Scler       Date:  2004-02       Impact factor: 6.312

8.  Impact of aerobic training on immune-endocrine parameters, neurotrophic factors, quality of life and coordinative function in multiple sclerosis.

Authors:  Karl-Heinz Schulz; Stefan M Gold; Jan Witte; Katharina Bartsch; Undine E Lang; Rainer Hellweg; Rüdiger Reer; Klaus-Michael Braumann; Christoph Heesen
Journal:  J Neurol Sci       Date:  2004-10-15       Impact factor: 3.181

Review 9.  The multiple sclerosis functional composite: a new clinical outcome measure for multiple sderosis trials.

Authors:  R A Rudick; G Cutter; S Reingold
Journal:  Mult Scler       Date:  2002-10       Impact factor: 6.312

10.  Measuring the impact of MS on walking ability: the 12-Item MS Walking Scale (MSWS-12).

Authors:  J C Hobart; A Riazi; D L Lamping; R Fitzpatrick; A J Thompson
Journal:  Neurology       Date:  2003-01-14       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.